Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Science of MDHAQ/RAPID3 Scores

Theodore Pincus, MD  |  Issue: December 2011  |  December 12, 2011

An “evidence-based visit” in usual rheumatology care–beyond clinical trials and other research–appeared possible based on the Health Assessment Questionnaire (HAQ) and Arthritis Impact Measurement Scale (AIMS), which appeared in Arthritis & Rheumatism in 1980, the same year in which I moved to Vanderbilt University.1,2 I had been a junior faculty member at Stanford in 1975, as director of the Clinical Immunology Laboratory and a basic virology researcher–hardly a health services researcher. However, interactions with Jim Fries, MD, and Hal Holman, MD, fellow faculty members at Stanford and developers of the HAQ, had prepared me to recognize that quantitative, “scientific” data could emerge from usual clinical care, as well as from the laboratory.

Clinical measurement had long been a major interest, initially as a student in 1961 when I performed erythrocyte sedimentation rates (ESRs) in the Columbia University laboratory of Charles Christian, MD. This interest was expressed in 1969 in development of a radioimmunoassay for DNA antibodies, so that a diagnosis of systemic lupus erythematosus (SLE) could be based on a routine clinical test rather than a “research test.”3 Clinical decisions in rheumatoid arthritis (RA) in 1980 (and today) were based primarily on information from the patient, rather than laboratory tests, although laboratory tests were (and often remain) the only quantitative clinical information in the medical record. Self-report questionnaires could document patient history information concerning physical function and pain as quantitative scores, rather than as gestalt, nonquantitative descriptions (e.g., “ ‘doing well’ while the patient has become progressively crippled before their eyes”).4 Standard, quantitative, patient self-report data could meet criteria for “scientific” measures, similar to laboratory tests.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

click for large version
Table 1: Comparison of HAQ and MDHAQ

Theory into Practice

To incorporate quantitative clinical measurement in clinical care, I asked the Vanderbilt clinic receptionists to distribute a HAQ to patients before they saw me. This practice was implemented and maintained easily over 27 years, although the receptionists were employees of the nursing service (rather than the physicians) and turned over frequently. Review of the information provided by the patients on questionnaires was very helpful prior to performing my own history and physical examination. Leigh Callahan, PhD, Christopher Swearingen, PhD, and Raye Brooks, colleagues at Vanderbilt, helped to establish a database to provide flowsheets of quantitative self-report clinical scores, along with traditional laboratory tests and medications for all visits of all patients (with any diagnosis).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
click for large version
Table 2: Cross-Sectional Analysis of RA Patients Seen by Dr. Pincus in 1985 vs. 2000

Routine completion of a HAQ in my clinic led to several changes to provide additional clinically useful information within a two-sided one-page format. The original 20 HAQ activities in eight categories were compressed to eight activities, one from each category; activities performed by all people each day were included (e.g., “shampoo your hair” was deleted). Queries concerning “aids, devices, or help from another person” were dropped, since they were usually negative and complicated scoring. A modified HAQ (MHAQ) reported in 1983 described similar results to the HAQ, though with scores lower by about 0.3 units because simplest activities were included.5 These were initial efforts in a continuous quality improvement (CQI) process that has lasted more than 25 years involving further modifications of the original two-sided, one-sheet HAQ (see Table 1), ultimately leading to a multidimensional HAQ (MDHAQ) (see Figures 1 and 2).6-8

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:Diagnostic Criteriaevidence-based medicineHealth Assessment Questionnairepatient carerheumatology

Related Articles

    Remote Use of the Multidimensional Health Assessment Questionnaire (MDHAQ)

    December 18, 2019

    The patient medical history is far more prominent in clinical decisions for rheumatology than for many common chronic diseases in which a gold standard biomarker, such as blood pressure or serum glucose, is applicable to diagnosis and management of all individual patients.1 Components of a subjective patient history may be recorded as structured, quantitative, standard,…

    The Peripatetitc Theodore Pincus, MD

    July 1, 2007

    Tireless champion for patient self-report

    Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

    April 1, 2013

     Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

    Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate

    March 1, 2015

    Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences